Where Does Your Organization Stand: How will Your Work be Affected by the Opioid Crisis? (1.5 CEs)
Andrew Martin, MBA, LAADC
Harry Nelson, JD
Supported by: Behavioral Health Association of Providers & Nelson Hardiman
Time: 10:45 AM – 12:15 PM
Level of Instruction: Introductory/Intermediate
This presentation will examine the most recent data relating to the United States opioid crisis and how the crisis challenges present-day healthcare services pertaining to licensing, freedom to practice evidence-based treatment interventions, and ability to choose abstinence-based treatment modalities. It will further investigate the therapeutic responses to the opioid crisis to date and hypothesize about the government’s therapeutic stance that can be expected in the future. Furthermore, the presentation will present best practices with regard to incorporating Medication Assisted Treatment into SUD treatment service offerings including clinical licensure requirements and OTP requirements. We will also discuss how to address the therapeutic concerns surrounding MAT, including segregation of patients, handling abstinence controversy, and methods for addressing the titration wishes of the client.